Pain Therapeutics
Seite 1 von 2 Neuester Beitrag: 25.04.21 00:01 | ||||
Eröffnet am: | 09.01.18 17:56 | von: Kurios1 | Anzahl Beiträge: | 32 |
Neuester Beitrag: | 25.04.21 00:01 | von: Jenniferhukg. | Leser gesamt: | 11.502 |
Forum: | Hot-Stocks | Leser heute: | 8 | |
Bewertet mit: | ||||
Seite: < | 2 > |
negatives Remoxy Panel Vote (3-14)
https://www.fiercebiotech.com/...eutics-abuse-deterrent-opioid-remoxy
http://investor.paintrials.com/news-releases/...018-financial-results
Kapitalerhöhung zu 1,15$
"Pain Therapeutics, Inc. a biopharmaceutical company, today announced the closing of its previously announced registered direct offering of 8,860,778 shares of its common stock, which was priced at-the-market at a purchase price of $1.15 per share, for gross proceeds of approximately $10.19 million."
Wenn zu 6,8 Mio Aktien noch 8,9 Mio. neue Aktien hinzukommen kann man schon von einer enormen Verwässerung reden.
http://investor.paintrials.com/news-releases/...13-million-registered
Investor Call am 4. Oktober 2018
"Pain Therapeutics, Inc. , a biopharmaceutical company, today announced that it will host a live conference call to provide a strategic update regarding its business, its science and its pipeline. The call is scheduled to be held Thursday, October 4th at 10 AM Eastern time, 9 AM Central time."
https://www.nasdaq.com/de/symbol/ptie/real-time
Pain Therapeutics bekommt 3,5 Mio. $ "Forschungsgelder" vom NIH
Die Marktteilnehmer hatten offenbar andere News erwartet/erhofft.
https://www.sec.gov/Archives/edgar/data/1069530/...0181004xex99_1.htm